Inovio Pharmaceuticals Inc (INO.A)

INO.A on American Stock Exchange

0.89USD
1 Jul 2013
Price Change (% chg)

$0.09 (+11.80%)
Prev Close
$0.80
Open
$0.82
Day's High
$1.00
Day's Low
$0.82
Volume
614,692
Avg. Vol
153,343
52-wk High
$1.00
52-wk Low
$0.44

INO.A

Chart for INO.A

About

Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such... (more)

Overall

Beta: 3.10
Market Cap (Mil.): $143.25
Shares Outstanding (Mil.): 179.94
Dividend: --
Yield (%): --

Financials

  INO.A Industry Sector
P/E (TTM): -- 34.05 33.02
EPS (TTM): -0.14 -- --
ROI: -48.62 -2.50 19.07
ROE: -50.88 -3.10 20.00
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $27.78 -0.23
Novartis AG (NOVN.VX) CHF67.30 +0.20
Merck & Co., Inc. (MRK.N) $46.32 -0.13
Roche Holding Ltd. (ROG.VX) CHF234.60 -0.40
Sanofi SA (SASY.PA) €79.87 +0.25
AstraZeneca plc (AZN.L) 3,151.00p +36.00
GlaxoSmithKline plc (GSK.L) 1,658.50p +10.50
Crucell N.V. (CRCL.AS) -- --
Transgene SA (TRNG.PA) €9.09 -0.02

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$58.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks